Q4 2021 Neoleukin Therapeutics Inc Earnings Call Transcript
Good afternoon, and thank you for joining us today for Neoleukin Therapeutics conference call. (Operator Instructions) As a reminder, today's conference call is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, Please go ahead.
Thank you. Good afternoon, and welcome to Neoleukin Therapeutics Year-End 2021 Conference Call. Joining me on the call today from Neoleukin are Jonathan Drachman, CEO; Priti Patel, CMO; and Sean Smith, Vice President, Finance. Today's call is being recorded. It will be available for replay on the Investor Relations section of the Neoleukin website approximately 2 hours after the call for at least 30 days.
Before we start, I'd like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgments, intentions, beliefs and expectations about future events, strategies, product candidates and operating
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
